Comparison of lipid profiles with APOA1 MspI polymorphism in obese children with hyperlipidemia

In Vivo

Volumn 25, Issue 3, 2011, Pages 425-430

  Toptas, Bahar ^a   Görmüş, Uzay ^a   Ergen, Arzu ^a   Gürkan, Hakan ^a   Keleşoǧlu, Fatih ^a   Darendeliler, Feyza ^a   Bas, Firdevs ^a   Dalan, Altay Burak ^a   Izbirak, Güldal ^b   Isbir, Turgay ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b YEDITEPE UNIVERSITY   (Turkey)

Author keywords

Apo AI; DGGE; Hyperlipidemia; Obesity; Polymorphism

Indexed keywords

APOLIPOPROTEIN A1; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; BODY MASS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; HUMAN; HYPERLIPIDEMIA; MALE; OBESITY; POLYMERASE CHAIN REACTION; SCHOOL CHILD;

EID: 79956365122     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Noller DT and Paulk D: Childhood obesity curbing an American epidemic. JAAPA 18: 12, 2005.
2. Grundy SM: Obesity, metabolic syndrome and cardiovascular disease. J Clin Endocrinol Metab 89(6): 2595-2600, 2004.
3. Choi YJ, Jo YE, Ahn SM, Jung SH, Kim HJ, Chung YS, Lee KW and Kim DJ: High plasma concentration of remnant lipoprotein cholesterol in obese children and adolescents. Diabetes Care 29(10), 2006.
4. Strauss R: Childhood obesity. Curr Probl Pediatr 29: 5-29, 1999.
5. Lavie CJ, Milani RV and Ventura HO: Obesity and cardiovascular disease. J Am Coll Cardiol 53: 1925-1932, 2009.
6. Groenendijk M, Cantor RM, Bruin TW and Dallinga-Thie GM. The apoAI-CIII-AIV gene cluster. Atherosclerosis 157: 1-11, 2001. (Pubitemid 32539348)
7. Reguero JR, Cubero GI, Batalla A, Alvarez V, Hevia S, Cortina A and Coto E: Apolipoprotein Al gene poymorphisms and risk of early coronary disease. Cardiology 90: 231-235, 1998. (Pubitemid 29039148)
8. Kontush A and Chapman MJ: Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol Rev 58: 342-374, 2006. (Pubitemid 44394906)
9. Chen ES, Mazzotti DR, Furuya TK, Cendorogio MS, Ramos R, Araujo LQ, Burbano RR and Smith CM: Apolipoprotein A1 gene polymorphisms as risk factors for hypertension and obesity. Clin Exp Med 0051-3, 2009.
10. Gonzalez-Ameiva A, Lopez-Miranda J, Marin C, Prez- Marinez P, Gomez P, Paz-Rojas E, Arizon JM, Jimenez-Pereperz JA, Concha M and Perez-Jimenez F: The Apo A-I gene promoter region polymorphism determines the severity of hyperlipidemia after heart transplation. Clin Transplant 17: 56-62, 2003. (Pubitemid 36621648)
11. Freedmam DS, Dietz WH, Srinivasan SR and Berenson GS: The relation of overweight to cardiovascular risk factors among children and adolescents: The Bogalusa Heart Study. Pediatrics 103: 1175-1182, 1999. (Pubitemid 29258789)
12. Wang XL, Badenhop R, Humphrey K and Wilcken DEL: New MspI polymorphism at +83 bp of the human apolipoprotein AI gene: association with increased circulating high density lipoprotein cholesterol levels. Genet Epidemiol 13: 1-10, 1996.
13. Cole TJ, Bellizzi MC, Flegal KM and Dietz WH: Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 320: 1240-1243, 2000. (Pubitemid 30240471)
14. Jolliffem CJ and Janssen I: Distribution of lipoproteins by age and gender in adolescents. Circulation 114: 1056, 2006.
15. Meng Q, Pajukanta P, Valsta L, Aro A, Pietinen P and Tikkanen M, Influence of apolipoprotein polymorphism on lipid levels and responses to dietary change in Finnish adults. J Inter Med 241: 373-378, 1997. (Pubitemid 27244661)
16. Ercolini D: PCR-DGGE fingerprinting: novel strategies for detection of microbes in food. J Microbiol Met 56: 297-314, 2004.
17. Myers RM, Maniatis T and Lerman LS: Detection and localization of single base changes by denaturing gradient gel electrophoresis. Methods Enzymol 155: 501-527, 1987.
18. Nisoli E and Carruba M: Emerging aspects of pharmacotherapy for obesity and metabolic syndrome. Pharmacological Res 50: 453-469, 2004. (Pubitemid 39349046)
19. Steinberger J and Daniels SR: Obesity, insulin resisitance diabetes and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Commitee (Council on Nutrition, Physcal Activity, and Metabolism). Circulation 107: 1448-1453, 2003. (Pubitemid 36350747)
20. Pagani F, Sidoli A, Giudici GA, Barenghi L, Vergani C and Baralle FE: Human apolipoprotein A-I gene promoter polymorphism: association with hyperalphalipoproteinemia. J Lipid Res 31: 1371-1377, 1990. (Pubitemid 20261901)
21. Angotti E, Mele E, Costanzo F and Avvedimento EV: A polymorphism (G to A transition) in the -78 position of the apolipoprotein A-I promoter increases transcription efficiency. J Biol Chem 269: 17371-17374, 1994.
22. Talmud PJ, Shu Y and Humphries SE: Polymorphism in the promoter region of the apolipoprotein A-I gene associated with differences in apolipoprotein A-I levels: the European Atherosclerosis Research Study. Genet Epidemiol 11: 265-280, 1994. (Pubitemid 24184735)
23. Saha N, Tay JSH, Low PS and Humphries SE: Guanidine to adenine (G/A) substitution in the promoter region of the apolipoprotein A-I gene is associated with elevated serum apolipoprotein A-I levels in Chinese non-smokers. Genet Epidemiol 11: 255-264, 1994. (Pubitemid 24184734)
24. Peacock RE, Hamsten A, Johansson J, Nilsson-Ehle P and Humphries S: Association of genotypes at the apolipoprotein AI-CIII-AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses. Clin Genet 46: 273-282, 1994.
25. Peacock RE, Temple A, Gudnason V, Rosseneu M and Humphries SE: Variation at the lipoprotein lipase and apolipoprotein AI-CIII gene loci are associated with fasting lipid and lipoprotein traits in a population sample from Iceland: interaction between genotype, gender, and smoking status. Genet Epidemiol 14: 265-282, 1997. (Pubitemid 27240933)
26. Kamboh MI, Aston CE, Nestlerode CM, McAllister AE and Hamman RF: Haplotype analysis of two APOA1/MspI polymorphisms in relation to plasma levels of apo A-I and HDL-cholesterol. Atherosclerosis 127: 255-262, 1996. (Pubitemid 27045839)
27. Xu CF, Angelico F, Del Ben M and Humphries S: Role of genetic variation at the apo AI-CIII-AIV gene cluster in determining plasma apo AI levels in boys and girls. Genet Epidemiol 10: 113-122, 1993. (Pubitemid 23180566)
28. Carmena R, Ordovas J, Ascaso J, Real J and Priego M: Influence of genetic variation at the apo A-I gene locus on lipid levels and response to diet in familia hypercholesterolemia. Atherosclerosis 139: 107-113, 1998. (Pubitemid 28341872)